Protagenic Therapeutics Inc (PTIX)

$3.29 -0.01 (-0.30%)
Market Cap 1.94M
Revenue (ttm) 0.00
Net Income (ttm) -5.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 141,900
Avg Vol 3,401,484
Day's Range N/A - N/A
Shares Out 589,000.00
Stochastic %K 4%
Beta 0.38
Analysts Strong Buy
Price Target $4.00

Company Profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Industry: Biotechnology
Sector: Healthcare
Phone: (805) 699-5596
Address:
701 Anacapa Street, Suite C, Santa Barbara, United States
TradeSmart2
TradeSmart2 Oct. 3 at 9:21 PM
$PTIX Though merger oft to a rocky start looking like it will proceed as planned..Good for all shareholders..we should see a Boost from ABTI/Phytanix shareholders Once merger is fully understood. We need more Transparency from company regarding this as well as promised results..which is imminent(timing uncertain) imho
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 7:43 PM
$WAI $SLGL $PTIX $PBM Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 12:54 AM
$SLGL $PTIX $PBM $NIVF "
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:44 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $PTIX $PBM $NIVF $LITM
0 · Reply
Orig04
Orig04 Oct. 2 at 1:27 PM
$PTIX They said Quality data will be available in September. We are in Oct 1st week now! Companies are usually careful about what they say. I'm wondering if they didn't mean that a PR about the quality data shall be issued in Sep! If that's the case, it's gonna take a little more wait! Someone else keep me honest plz..
1 · Reply
MS1974
MS1974 Oct. 1 at 10:27 PM
$PTIX News coming,maybe moment huge up!
0 · Reply
Orig04
Orig04 Sep. 30 at 3:10 PM
$PTIX Today's price action boggles my mind!! Holding firm and looking for the quality data PR! Should be anytime now..
0 · Reply
ClintNorthwood
ClintNorthwood Sep. 30 at 2:16 PM
$PTIX the market cap has tripled? WTF!!!!
1 · Reply
sadie444
sadie444 Sep. 30 at 2:02 PM
$PTIX looks like a takedown attempt to see if they can pull out any stop losses prior to the next move. This has happened a couple times prior to spikes so we’ll have to see what happens over the next 48 hours.
0 · Reply
MS1974
MS1974 Sep. 30 at 1:59 PM
$PTIX Down to $2 and than moment again😂
0 · Reply
Latest News on PTIX
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

Aug 22, 2025, 5:25 PM EDT - 6 weeks ago

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Aug 21, 2025, 8:12 AM EDT - 6 weeks ago

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

May 21, 2025, 9:15 AM EDT - 4 months ago

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

May 19, 2025, 1:40 PM EDT - 4 months ago

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

May 19, 2025, 7:43 AM EDT - 4 months ago

Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Apr 29, 2025, 4:00 PM EDT - 5 months ago

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Nov 5, 2024, 8:12 AM EST - 11 months ago

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Oct 29, 2024, 9:27 AM EDT - 1 year ago

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial

May 1, 2024, 8:38 AM EDT - 1 year ago

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial

Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit

Apr 17, 2024, 8:42 AM EDT - 1 year ago

Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit

Protagenic Therapeutics, Inc. (PTIX) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 9:32 PM EDT - 1 year ago

Protagenic Therapeutics, Inc. (PTIX) Q4 2023 Earnings Call Transcript

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results

Apr 1, 2024, 4:20 PM EDT - 1 year ago

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

Mar 27, 2024, 8:42 AM EDT - 1 year ago

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Mar 25, 2024, 5:00 PM EDT - 1 year ago

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice

Mar 21, 2024, 8:41 AM EDT - 1 year ago

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice

Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

Feb 13, 2024, 8:30 AM EST - 1 year ago

Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

Oct 13, 2023, 9:00 AM EDT - 2 years ago

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Sep 26, 2023, 8:18 AM EDT - 2 years ago

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split

Mar 22, 2023, 12:55 PM EDT - 2 years ago

Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

Apr 26, 2022, 8:15 AM EDT - 3 years ago

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

Nov 16, 2021, 9:58 AM EST - 4 years ago

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Aug 30, 2021, 9:15 AM EDT - 4 years ago

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

Aug 17, 2021, 7:45 AM EDT - 4 years ago

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

Protagenic Therapeutics To Start Clinical Trials For Depression Candidate By 2021 End

Jul 26, 2021, 6:31 AM EDT - 4 years ago

Protagenic Therapeutics To Start Clinical Trials For Depression Candidate By 2021 End

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

Jul 23, 2021, 4:21 PM EDT - 4 years ago

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET

Jul 6, 2021, 6:17 AM EDT - 4 years ago

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET

Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th

Jun 16, 2021, 9:15 AM EDT - 4 years ago

Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th

Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq

Apr 29, 2021, 3:06 PM EDT - 4 years ago

Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering

Apr 26, 2021, 8:58 PM EDT - 4 years ago

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering

TradeSmart2
TradeSmart2 Oct. 3 at 9:21 PM
$PTIX Though merger oft to a rocky start looking like it will proceed as planned..Good for all shareholders..we should see a Boost from ABTI/Phytanix shareholders Once merger is fully understood. We need more Transparency from company regarding this as well as promised results..which is imminent(timing uncertain) imho
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 7:43 PM
$WAI $SLGL $PTIX $PBM Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 12:54 AM
$SLGL $PTIX $PBM $NIVF "
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:44 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $PTIX $PBM $NIVF $LITM
0 · Reply
Orig04
Orig04 Oct. 2 at 1:27 PM
$PTIX They said Quality data will be available in September. We are in Oct 1st week now! Companies are usually careful about what they say. I'm wondering if they didn't mean that a PR about the quality data shall be issued in Sep! If that's the case, it's gonna take a little more wait! Someone else keep me honest plz..
1 · Reply
MS1974
MS1974 Oct. 1 at 10:27 PM
$PTIX News coming,maybe moment huge up!
0 · Reply
Orig04
Orig04 Sep. 30 at 3:10 PM
$PTIX Today's price action boggles my mind!! Holding firm and looking for the quality data PR! Should be anytime now..
0 · Reply
ClintNorthwood
ClintNorthwood Sep. 30 at 2:16 PM
$PTIX the market cap has tripled? WTF!!!!
1 · Reply
sadie444
sadie444 Sep. 30 at 2:02 PM
$PTIX looks like a takedown attempt to see if they can pull out any stop losses prior to the next move. This has happened a couple times prior to spikes so we’ll have to see what happens over the next 48 hours.
0 · Reply
MS1974
MS1974 Sep. 30 at 1:59 PM
$PTIX Down to $2 and than moment again😂
0 · Reply
ClintNorthwood
ClintNorthwood Sep. 30 at 1:59 PM
$PTIX WTF?
0 · Reply
teejmack
teejmack Sep. 30 at 1:54 PM
$PTIX did we miss some bad news?
0 · Reply
bigD84
bigD84 Sep. 30 at 1:52 PM
$PTIX did I miss some news? Volume not too big
0 · Reply
MS1974
MS1974 Sep. 29 at 9:01 PM
$PTIX I buy QURE every day and it's pretty good...it's stagnant here,zero spiel !!!
0 · Reply
sadie444
sadie444 Sep. 29 at 3:05 PM
$PTIX  no shares traded in close to an hour. WOW. Anyone who is short of this is trapped going into the news that is due any moment.
0 · Reply
sadie444
sadie444 Sep. 26 at 3:28 PM
$PTIX Wow, volume has just dried up entirely on this. On the good news front, it is retaining its value very well this week considering the lack of volume. With news pending at any moment on top line results from the study this is set to spike on any news.
0 · Reply
Flowjob
Flowjob Sep. 26 at 2:55 PM
$PTIX next week!
0 · Reply
Orig04
Orig04 Sep. 25 at 6:43 PM
$PTIX This is holding up well amongst a sea of red. Buying interest on a day like this is not common!! Waiting for the 5 handle to arrive soon!!
0 · Reply
makedatbread88
makedatbread88 Sep. 25 at 5:52 PM
$PTIX adding here catalyst due any day “Following successful completion of a single ascending dose trial demonstrating favorable safety, the company anticipates topline safety data by September 2025 and plans to advance to Phase 2 efficacy studies in Q1 2026.“
0 · Reply
frankyboyz
frankyboyz Sep. 25 at 3:06 PM
$PTIX aint a pr due?
0 · Reply
Orig04
Orig04 Sep. 25 at 2:06 AM
$PTIX I feel this has held up pretty decently despite the pullback in the markets this week. We are still holding above the highs of last week. I hope we don't lose the 4 handle and get past the 4.50 to close the week! Even better if the data is released!!
0 · Reply
Orig04
Orig04 Sep. 25 at 1:51 AM
$PTIX So the company had set the expectation that they will share the Quality data in September. Only 4 working days left now!! Can someone with experience chime in and tell if these are rough timelines and subject to slippage?
1 · Reply